Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Milestone Pharmaceuticals Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −3 vs. Q1 2024
- Shares held
- 30.2M
- −1.16M (−3.7%) vs. Q1 2024
- Total value
- $39.9M
- −$16.5M (−29.3%) vs. Q1 2024
- New holders
- 3
- 9 more added
- Sold out
- 6
- 6 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 4,971,344 | $6.56M | 0.00% | 00.0% | Unchanged |
| RTW Investments, LP | 3,256,102 | $4.30M | 0.07% | 00.0% | Unchanged |
| Millennium Management LLC | 2,749,930 | $3.66M | 0.00% | −105,682−3.7% | Reduced |
| Alta Fundamental Advisers LLC | 2,658,589 | $3.51M | 1.53% | +287,300+12.1% | Added |
| Lion Point Capital, LP | 2,340,207 | $3.09M | 9.67% | +40,000+1.7% | Added |
| Citadel Advisors LLC | 2,147,344 | $2.86M | 0.00% | −125,060−5.5% | Reduced |
| OrbiMed Advisors LLC | 2,000,000 | $2.64M | 0.06% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,750,000 | $2.31M | 0.23% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 1,353,067 | $1.79M | 0.00% | 00.0% | Unchanged |
| Bleichroeder LP | 1,326,085 | $1.75M | 0.52% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 1,239,199 | $1.64M | 1.49% | −223,097−15.3% | Reduced |
| BML Capital Management, LLC | 1,102,895 | $1.46M | 1.07% | +496,750+82.0% | Added |
| Altium Capital Management LP | 1,012,368 | $1.34M | 0.55% | −200,514−16.5% | Reduced |
| Morgan Stanley | 828,654 | $1.09M | 0.00% | +8,826+1.1% | Added |
| Ikarian Capital, LLC | 466,019 | $619.8K | 0.19% | 00.0% | Unchanged |
| Boxer Capital, LLC | 309,007 | $407.9K | 0.02% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 202,460 | $267.2K | 0.05% | 00.0% | Unchanged |
| Ancora Advisors, LLC | 60,000 | $79.2K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 59,523 | $78.6K | 0.00% | +7,690+14.8% | Added |
| Squarepoint Ops LLC | 54,684 | $72.7K | 0.00% | +54,684 | New |
| Dimensional Fund Advisors LP | 39,450 | $52.4K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 30,779 | $40.6K | 0.00% | 00.0% | Unchanged |
| Atria Investments LLC | 27,991 | $36.9K | 0.00% | +27,991 | New |
| Northern Trust Corp | 27,784 | $36.7K | 0.00% | −532−1.9% | Reduced |
| BNP Paribas Arbitrage, SA | 24,600 | $32.7K | 0.00% | +7,700+45.6% | Added |
| Cetera Investment Advisers | 20,689 | $27.3K | 0.00% | +3,262+18.7% | Added |
| Clear Creek Financial Management, LLC | 19,500 | $25.7K | 0.00% | −5,500−22.0% | Reduced |
| State Street Corp | 18,923 | $25.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 17,576 | $23.4K | 0.00% | 00.0% | Unchanged |
| Beta Wealth Group, Inc. | 14,127 | $18.6K | 0.01% | 00.0% | Unchanged |
| Creative Planning | 13,080 | $17.3K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 10,500 | $13.9K | 0.00% | 00.0% | Unchanged |
| Valeo Financial Advisors, LLC | 10,000 | $13.2K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 7,100 | $9.40K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,500 | $8.58K | 0.00% | +500+8.3% | Added |
| Jones Financial Companies LLLP | 1,070 | $1.41K | 0.00% | +1,070 | New |
| Simplex Trading, LLC | 1,191 | $1.00K | 0.00% | +713+149.2% | Added |
| Qube Research & Technologies Ltd | 194 | $258 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 100 | $132 | 0.00% | 00.0% | Unchanged |
| Oliver Lagore Vanvalin Investment Group | 100 | $132 | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −650,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −273,100−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −13,403−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,618−100.0% | Sold out |
| ICA Group Wealth Management, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |